Pharmacy

Ketolides Market Expects Robust Growth With Rising Infectious Disease Prevalence - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 26, 2024
Infectious Diseases, Pharmaceutical, Health, Ketolide, Sinusitis, Pharmacy, Infection, Urinary tract infection, Hospital, Prevalence, Antimicrobial stewardship, Tuberculosis, Pharmaceutical industry

The global ketolides market is poised for steady expansion, driven by the growing need for effective treatments for infectious diseases and an upsurge in healthcare investments.

Key Points: 
  • The global ketolides market is poised for steady expansion, driven by the growing need for effective treatments for infectious diseases and an upsurge in healthcare investments.
  • According to the latest market research report, the ketolides market showcases a promising compound annual growth rate (CAGR), signaling a positive trajectory from $3.07 billion in 2023 to a projected value of $3.82 billion by 2028.
  • It also identifies emerging trends in targeted therapies and advancements in diagnostic procedures that are augmenting the ketolides market landscape.
  • The report underscores North America's dominance in the ketolides arena, attributable to robust healthcare infrastructure, comprehensive screening programs, and a heightened focus on infectious disease control.

Amber Specialty Pharmacy Selected to Dispense Rezdiffra™ to Treat Noncirrhotic Non-Alcoholic Steatohepatitis

Retrieved on: 
Monday, March 25, 2024
Retail, Health, Other Health, Supermarket, Specialty, Pharmaceutical, F2, NASH, Diet, FDA, Cirrhosis, Exercise, Pharmacy

"Adding Rezdiffra to our patient care portfolio allows Amber Specialty Pharmacy to remain at the forefront of providing specialized medications that not only change lives, but also embody our commitment to innovation and excellence in health care,” said Jessica Ringena, president of Amber Specialty Pharmacy.

Key Points: 
  • "Adding Rezdiffra to our patient care portfolio allows Amber Specialty Pharmacy to remain at the forefront of providing specialized medications that not only change lives, but also embody our commitment to innovation and excellence in health care,” said Jessica Ringena, president of Amber Specialty Pharmacy.
  • “With Rezdiffra, we are focused on delivering transformative care in a way that positively impacts the lives of those battling chronic liver conditions."
  • For more than 25 years, Amber Specialty Pharmacy has delivered specialized care to individuals across the U.S. who live with chronic and complex health conditions.
  • Amber Specialty Pharmacy offers a range of comprehensive services that include medication management, therapy-specific counseling and 24/7 clinical support.

Fabric Appoints Curt Avallone as Co-CEO Alongside Current CEO Avi (Jack) Jacoby

Retrieved on: 
Monday, March 25, 2024
Software, Mobile, Wireless, Networks, Other Retail, Online Retail, Internet, Hardware, Data Management, Payments, Electronic Commerce, Technology, Retail, Other Technology, Giant, E-commerce, Automation, Growth, CVS Pharmacy, Research, Pharmacy, Avallone, Harvard Business Review, HEB, Multimedia, Ahold Delhaize, Giant Eagle, Management

Fabric , the technology company reshaping retail fulfillment, today announced Curt Avallone has joined the company as Co-CEO.

Key Points: 
  • Fabric , the technology company reshaping retail fulfillment, today announced Curt Avallone has joined the company as Co-CEO.
  • View the full release here: https://www.businesswire.com/news/home/20240325411728/en/
    Fabric Appoints Curt Avallone as Co-CEO (Photo: Business Wire)
    “I’m thrilled to be in a position to lead an organization that offers the best-in-class solution for local eGrocery needs,” Avallone said.
  • Longtime company executive Avi (Jack) Jacoby will remain with Fabric as co-CEO.
  • Jacoby joined the company in 2018 as Chief of Staff, later became CEO of the Israel market, and then chief operating officer.

AHF Cheers Washington State Law to Stop PBM Abuse

Retrieved on: 
Tuesday, March 26, 2024
State, Local, Public Policy, Healthcare Reform, Pharmaceutical, Social Activism, Practice Management, Communications, Managed Care, Philanthropy, Advocacy Group Opinion, Infectious Diseases, Government, Foundation, AIDS, Health, AIDS Healthcare Foundation, Patient, Pharmacy, AHF

Today, Washington Governor Jay Inslee signed SB 5213 into law.

Key Points: 
  • Today, Washington Governor Jay Inslee signed SB 5213 into law.
  • The law protects patients and the pharmacies who serve them from pharmacy benefit managers (PBMs).
  • “We thank Senator Kuderer, Senator Short and the Washington State Pharmacy Association for championing this bill.
  • This bill provides protections for patient care, patient choice and pharmacies,” said Laura Boudreau, Chief of Operations at AIDS Healthcare Foundation (AHF), which worked with the legislators and the Washington State Pharmacy Association to ensure passage of the bill.

HealthWarehouse.com Reports Full Year 2023 Results

Retrieved on: 
Monday, March 25, 2024
Software, Pharmaceutical, Medical Supplies, Health, Technology, Electronic Commerce, Online Retail, Retail, Tax, Bankruptcy, Growth, Pharmacy, Annual general meeting, Acquisition, Prescription, B2C, Adjustment, Advertising, NABP, Depreciation, GAAP, National Association, OTCQB, Marketing, Engineering

HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today its results of operations for the year ended December 31, 2023.

Key Points: 
  • HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today its results of operations for the year ended December 31, 2023.
  • Gross margin percentage decreased to 60.0% for the year ended December 31, 2023, from 65.8% for the year ended December 31, 2022.
  • Bad debt expense of $428,000 resulted from the termination of a potential fourth quarter 2023 acquisition, and the subsequent bankruptcy filing of that company.
  • Adjusted EBITDA for the fourth quarter of 2023 was $121,000, compared with $56,000 in the fourth quarter of 2022.

Curaleaf International Comments As German Federal Cannabis Law Passes Without Delay

Retrieved on: 
Friday, March 22, 2024
Science, Legal, Research, Natural Resources, Alternative Medicine, Health, Professional Services, Cannabis, Pillar, Bundestag, Growth, Environment, Cannabis Act, Patient, Sale, Prescription, Terra Verde, Insurance, Cabinet of Germany, Pharmacy, Curaleaf, Pharma, Legislation, Drug

Today, it has been announced that the German Federal Government's cannabis law, also known as Pillar 1, has successfully progressed without delay.

Key Points: 
  • Today, it has been announced that the German Federal Government's cannabis law, also known as Pillar 1, has successfully progressed without delay.
  • Juan Martinez, Head of Curaleaf International, a leading cannabis company in Europe, commented:
    "The successful passage of the Cannabis Act represents a significant milestone in our journey towards destigmatisation and decriminalisation of cannabis for both patients and consumers.
  • As a company deeply invested in the European cannabis landscape, we are excited about the opportunities this legislation brings.
  • Our full seed-to-sale process allows us first mover advantage to meet the anticipated demand from a thriving, regulated, and safe cannabis industry.

Sila Realty Trust, Inc. Completes Acquisition of $85.5 Million Healthcare Portfolio in Arizona and Texas

Retrieved on: 
Friday, March 22, 2024
Health, Hospitals, Other Health, Construction & Property, General Health, REIT, Abrazo Community Health Network, Acquisition, Pharmacy, Google Images, Tenet Healthcare, Bed, MSA, Hospital

The Portfolio is comprised of four built-to-suit micro-hospitals and one freestanding emergency department, totaling approximately 158,000 square feet on a combined 17.5 acres.

Key Points: 
  • The Portfolio is comprised of four built-to-suit micro-hospitals and one freestanding emergency department, totaling approximately 158,000 square feet on a combined 17.5 acres.
  • Each of the micro-hospitals is licensed for 8-inpatient beds, and offers a 13-bed emergency department, operating room, laboratory, diagnostic imaging suite, and a pharmacy.
  • The freestanding emergency department is a 13-bed full-service emergency center, constructed to also offer the same services as the micro-hospitals.
  • One micro-hospital and the freestanding emergency department are in the Tucson, Arizona MSA and operate under the brand of Carondelet Health.

Modular Laboratory Automation Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Thermo Fisher Scientific, Danaher, Becton Dickinson, Siemens, and Honeywell - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 21, 2024
Robotics, Technology, Manufacturing, Other Science, Science, Machinery, Growth, Drug discovery, Pharmacy, Software, Investment, M&A, Porter's five forces analysis, Fine chemical

The "Modular Laboratory Automation Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Modular Laboratory Automation Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global modular laboratory automation market grow with a CAGR of 6.5% from 2024 to 2030.
  • The future of the global modular laboratory automation market looks promising with opportunities in the drug discovery, genomic, proteomic, and clinical diagnostic markets.
  • Growth Opportunities: Analysis of growth opportunities in different equipment and softwares, applications, and regions for the modular laboratory automation market.

Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners

Retrieved on: 
Thursday, March 21, 2024
Supermarket, Health Technology, Pharmaceutical, Oncology, Teens, Medical Devices, Parenting, Infectious Diseases, Retail, Genetics, Fitness & Nutrition, Cardiology, Health, Seniors, Practice Management, Men, General Health, Family, Consumer, Diabetes, Other Retail, Other Health, Biometrics, Diagnosis, Temperature, Patient, Pharmacy, Pharmacist, Prescription, Babson, Insurance, Centrifugation, Texas Pharmacy Association, Collection, Blood, FDA

Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.

Key Points: 
  • Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.
  • BetterWay brings blood testing into the 21st century, making it less invasive, more convenient, and accessible for consumers.
  • “Blood testing hasn’t changed much in over 70 years,” said David Stein, Babson’s chief executive officer.
  • Without the need for a phlebotomist, Babson can bring medically accurate blood testing to new, more convenient settings such as community pharmacies.

TrueRx: AI-Powered Monitoring and Alert System Is the Industry’s First Prescription for Fraud

Retrieved on: 
Wednesday, March 20, 2024
Software, Pharmaceutical, Internet, Health, Artificial Intelligence, Technology, Mobile, Wireless, Other Health, Risk, Patient, Pharmacy, Algorithm, Pharmacist, Prescription

DrFirst’s new prescription monitoring solution – TrueRx – will give the nation’s pharmacies their first-ever standardized alert system to protect against prescriber identity and prescription fraud.

Key Points: 
  • DrFirst’s new prescription monitoring solution – TrueRx – will give the nation’s pharmacies their first-ever standardized alert system to protect against prescriber identity and prescription fraud.
  • There has been no system to aid pharmacists who receive fraudulent prescriptions.
  • When a prescription arrives at the pharmacy, digital fingerprint analysis alerts the pharmacist if one or more “behavior outliers” are detected that are typical in cases of stolen identity.
  • As methods of identity fraud become more complex, the algorithms will learn new behaviors to better prepare for the next style of attack.